A further subgroup analysis showed that low STK17B was correlated with worse OS in N and M Stage, pathologic stage, radiation therapy, gender, race, melanoma ulceration, age, melanoma Clark level, Breslow depth, tumor site, BRAF status of SKCM patients (Fig 2). This evidence concerns the gene STK17B and melanoma.